Abeona Therapeutics (ABEO) Preferred Dividend Payments (2011 - 2022)
Abeona Therapeutics (ABEO) recorded quarterly Preferred Dividend Payments of $3.8 million in Q2 2022, up 452.92% quarter-over-quarter from $684000.0 in Q4 2014.
Abeona Therapeutics (ABEO) Preferred Dividend Payments (2011 - 2022) Analysis & Trends
Abeona Therapeutics' Preferred Dividend Payments history runs 5 years deep, the most recent figure standing at $3.8 million for Q2 2022.
- In Q2 2022, Preferred Dividend Payments changed N/A year-over-year to $3.8 million; the TTM figure through Dec 2022 stood at $3.8 million (changed N/A YoY), while the FY2022 annual figure was $3.8 million, changed N/A from the prior year.
- Preferred Dividend Payments was $3.8 million for Q2 2022 at Abeona Therapeutics, up from $684000.0 in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $3.8 million in Q2 2022 to a low of $3.8 million in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Abeona Therapeutics | 309.15 Mn | 140.88 Mn | 6.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 3.78 Mn |
| Dec 31, 2014 | 684,000.00 |
| Sep 30, 2014 | 740,000.00 |
| Jun 30, 2014 | 726,000.00 |
| Mar 31, 2014 | 725,000.00 |
| Dec 31, 2013 | 696,000.00 |
| Sep 30, 2013 | 742,000.00 |
| Jun 30, 2013 | 733,000.00 |
| Mar 31, 2013 | 727,000.00 |
| Dec 31, 2012 | 676,000.00 |
| Sep 30, 2012 | 444,000.00 |
| Jun 30, 2012 | 439,000.00 |
| Mar 31, 2012 | 440,000.00 |
| Dec 31, 2011 | 447,000.00 |
| Sep 30, 2011 | 447,000.00 |
| Jun 30, 2011 | 442,000.00 |
| Mar 31, 2011 | 438,000.00 |